Experiment 1175348
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | WALTHER,PJ: WILLIAMS,SD: TRONER,M: GRECO,FA: BIRCH,R: EINHORN,LH:. (1986). PHASE II STUDY OF ETOPOSIDE FOR CARCINOMA OF THE BLADDER: THE SOUTHEASTERN CANCER STUDY GROUP EXPERIENCE.. 70(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II STUDY, 22 PATIENTS WITH ADVANCED CARCINOMA OF THE BLADDER WERE TREATED. DOSE REGIMEN CONSISTED OF 130 MG/SQ.M. INFUSED FOR 30 MIN. DAILY FOR 3 DAYS AND REPEATED EVERY 21 DAYS. OF 17 EVALUABLE PATIENTS, THERE WERE NO COMPLETE AND ONE PARTIAL REMISSION. ONE PATIENT DIED OF POSSIBLE DRUG-RELATED ALLERGIC REACTION. HEMATOLOGICAL TOXICITY WAS PREDOMINANTLY MODERATE, THOUGH THERE WERE 3 CASES OF LIFE THREATENING LEUKOPENIA. |
| Dose amount | 130.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |